Conelea, Christine
Breitenfeldt, Claire
Wilens, Alixandra
Carpenter, Linda
Greenberg, Benjamin
Herren, Jennifer
Jacob, Suma
Lewis, Charles
McLaughlin, Nicole
Mueller, Bryon A.
Nelson, Steve
O’Connor, Erin
Righi, Giulia
Widge, Alik S.
Fiecas, Mark
Benito, Kristen https://orcid.org/0000-0002-1908-9282
Article History
Received: 13 August 2024
Accepted: 11 November 2024
First Online: 18 December 2024
Declarations
:
: Advarra sIRB ABC123456 provided approval for this study. Written, informed consent to participate will be obtained from all participants (for those age 18 +) and parents or legal guardians (for those age 12–17). Written assent will also be obtained for youth age 12–17.
: Not applicable—no identifying images or other personal or clinical details of participants are presented here or will be presented in reports of the trial results. The participant information materials and informed consent form are available from the corresponding author on request.
: Dr. Nelson consults for Turing Medical, which commercializes FIRMM. This interest has been reviewed and managed by the University of Minnesota in accordance with its Conflict of Interest policies. The other authors declare that they have no competing interests.